Durysta is a biodegradable sustained-release implant that delivers bimatoprost, a medication used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. At SightMD, we offer Durysta as part of our dropless glaucoma care, helping patients experience long-term relief from eye pressure without the hassle of daily drops.
What is Durysta?
Durysta is a tiny, dissolvable implant placed in the anterior chamber of the eye. It slowly releases bimatoprost over several months, providing consistent pressure control. Once the medication is fully released, the implant naturally dissolves and does not need to be removed.
Who is Durysta for?
Durysta is a great option for:
- Patients with mild to moderate open-angle glaucoma or ocular hypertension
- Individuals who struggle with drop compliance
- Patients with sensitive eyes or allergies to preservatives in traditional drops
Durysta is not recommended for individuals with certain types of eye conditions, including corneal issues. A SightMD specialist will evaluate your eye health to determine eligibility.
Benefits of Durysta
- No Daily Drops: Offers up to six months of medication from a single implant.
- Biodegradable: Implant dissolves naturally in the eye.
- Stable Eye Pressure: Provides steady, reliable IOP control.
- Fewer Side Effects: Reduces exposure to preservatives and potential irritation.
- Convenient: Implanted in-office with minimal recovery time.
The Procedure: What to Expect
Durysta implantation is performed in the office and takes just a few minutes:
- Your eye is numbed with anesthetic drops.
- Using a specially designed applicator, your doctor inserts the Durysta implant into the anterior chamber.
- No stitches, incisions, or follow-up removals are needed.
Most patients experience no discomfort and return to daily activities shortly afterward.
What Happens Afterward?
You may be prescribed anti-inflammatory drops to use for a few days. SightMD will schedule follow-ups to monitor IOP and overall response. Durysta may be repeated if pressure rises again, though current FDA approval supports one-time use in each eye.
FAQs About Durysta
A: Clinical studies show IOP-lowering effects for about 4 to 6 months.
A: FDA approval currently allows one implant per eye. Your doctor will monitor pressure and recommend alternative treatments if needed.
A: No, it is not visible and does not cause discomfort.
A: As with any procedure, there are potential risks, including eye inflammation or corneal side effects. These are rare and monitored closely by your doctor.
Get Started with Dropless Care
If you’re looking for a reliable, low-maintenance solution for glaucoma, Durysta might be the right choice. SightMD’s expert team is here to guide you through every step of the process.
Book Your Evaluation Today
Call 855.295.4144 or visit SightMD.com to request a consultation.